Intravenous Infusions is trading at GHS 0.53, up 3.92%, with no verified catalyst identified in the September 30, 2026 price context.
- No company-specific announcement explaining the rise was identified. The latest GSE notice, dated September 25, concerned the appointment of a board chairman, not a stated reason for the move.
- Ghana’s main stock index fell 0.30% on September 29, so broad-market direction does not clearly explain the gain.
- The provided context includes no September 30 volume data.